NCT03821961 is a NA clinical trial of Metabolic Surgery in Diabetes Mellitus, Type 2, sponsored by Korea University Anam Hospital.

Who is sponsoring NCT03821961?

NCT03821961 is sponsored by Korea University Anam Hospital.

What drugs are being tested in NCT03821961?

Interventions in NCT03821961: Metabolic Surgery.

What condition does NCT03821961 study?

NCT03821961 studies Diabetes Mellitus, Type 2, PreDiabetes, Obesity.

Is NCT03821961 still recruiting?

NCT03821961 is currently status unknown. Last updated 26 February 2020.

Last reviewed 2020-02-26 · How we verify

NCT03821961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery

Status unknown NA Last updated 26 February 2020

What this trial tests

NA trial testing Metabolic Surgery in Diabetes Mellitus, Type 2 in 30 participants. Status unknown.

Timeline

3 September 2018

Primary endpoint
30 November 2020

31 December 2020

Quick facts

Lead sponsor	Korea University Anam Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	3 September 2018
Primary completion	30 November 2020
Estimated completion	31 December 2020
Sites	1 location across South Korea

Drugs / interventions tested

Metabolic Surgery

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
PreDiabetes — all drugs for PreDiabetes →
Obesity — all drugs for Obesity →

Sponsor

Korea University Anam Hospital

Who can join

19 and older, any sex, with Diabetes Mellitus, Type 2 or PreDiabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the endocrine function of pancreas between pre and post metabolic surgery in patients with type 2 diabetes or prediabetes. The study will examine the endocrine function of pancreas using 18F-FDOPA PET/CT imaging and various biochemical laboratory tests

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Metabolic Surgery

Trials testing the same drug.

NCT04583683 — Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities · NA · unknown

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Korea University Anam Hospital trials

Trials by the same sponsor.

NCT07510932 — Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients · Phase 2 · not yet recruiting
NCT07280780 — CGM-Based Glycemic Analysis After ESI · not yet recruiting
NCT07189000 — Patient-centered REhabilitation Program to Advance REcovery · NA · not yet recruiting
NCT07246148 — NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization · NA · recruiting
NCT07376980 — The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03821961 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Korea University Anam Hospital
Last refreshed: 26 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03821961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing